Pain in adults with Huntington's disease
Part of Brain & nervous system, Genetic & congenital, Mental health, Pain clinical trials.
This study looks at how people with Huntington's disease experience pain. It aims to understand pain better so that care can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older and have been diagnosed with adult-onset Huntington's disease (with a confirmed genetic test).
- You are generally healthy apart from Huntington's disease, or any other health conditions are stable and well-controlled.
- You are not in the late stage of the disease, as defined by a specific score (UHDRS-TFC score of 3 or higher).
- You do not have other medical or psychiatric conditions that would make it hard to take part.
- You have not had a history of drug or alcohol abuse in the past year, and you are not pregnant or breastfeeding.
- You are able to give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with Parkinson’s, treated either with levodopa or deep brain stimulation (DBS), and healthy volunteers experience pain. The goal is to understand how Parkinson’s treatments affect pain perception.
This study tests new ways to measure thinking and memory skills in people with Huntington's disease. It aims to find better tools for tracking the disease and could help you understand your cognitive changes.
This study tests whether a medication called pridopidine can help slow the progression of Huntington's disease symptoms in adults. Huntington's is a genetic disorder affecting movement, mood, and thinking, and this trial aims to see if pridopidine improves daily functioning and quality of life.
This study looks at how accurately people can describe their pain and related symptoms. It may help researchers improve how pain is measured in future studies.
This study is collecting tiny particles called extracellular vesicles from blood and spinal fluid to learn more about Huntington's disease. It aims to find better ways to measure the disease in people who have HD and in those who do not.
This study tests whether a gentle brain stimulation device (tDCS) used at home can help improve thinking and behavior in people with Huntington's disease. A caregiver is needed to be present during treatment and help with questionnaires.
Hear when a new Huntington Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.